Last checked at 4 Jun 2021 07:02
MyHealthChecked Plc
("MyHealthChecked" or the "Company")
Notice of Annual General Meeting
MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, announces that the Notice of Annual General Meeting ("AGM") and associated form of proxy will be sent to shareholders today.
The Company's AGM will be held at The Maltings, East Tyndall Street, Cardiff, CF24 5EA at 11.00am on Tuesday 29 June 2021.
Please note that, given that significant restrictions on personal movement are expected to remain in place due to COVID-19 and the Company's ongoing commitment to protect the health and wellbeing of its shareholders, officers and employees, the AGM will not be held in the usual manner. The Board requests that no Shareholders attend the AGM but that instead they appoint the Chairman of the AGM as their proxy. This will ensure that your vote is counted. Any Shareholders that do attend will be refused entry. Only those who are required to form the quorum will attend in person and those Shareholders will constitute the minimum quorum for the meeting to take place.
Given the constantly evolving nature of the situation, should circumstances change before the time of the AGM, the Company wants to ensure that it is able to adapt arrangements and to welcome Shareholders to the AGM, within safety constraints and in accordance with government guidelines. Should the Company consider that it has become possible to do so, the AGM will be open for all Shareholders to attend. We will notify Shareholders of the change via Regulatory Information Service as early as is possible before the date of the AGM. Any updates to the position will be included on our website at www.myhealthcheckedplc.com.
Shareholders should note that only the usual and formal business set out in the notice of AGM will be considered at the AGM. There will be no presentation by the directors nor any question and answer session.
Accordingly shareholders wishing to vote on any of the matters of business are urged to do so through completion of a proxy form. Proxy forms should be completed and returned in accordance with the instructions thereon so as to be received by the Company's registrars, Neville Registrars Limited, as soon as possible but in any event not later than 11.00 am on 25 June 2021.
Any shareholder who has a question is invited to contact the Company (by email to the Chairman of the Company, via Walbrook PR at myhealthchecked@walbrookpr.com by 25 June 2021 and the Company will post any answers on its website at www.myhealthcheckedplc.com after 5.00pm (BST) on Monday 28 June 2021.
The Annual Report and Accounts, Notice of AGM and associated form of proxy will be made available on the Company's website in due course www.myhealthcheckedplc.com
MyHealthChecked PLC | www.myhealthchecked.com |
Penny McCormick, Chief Executive Officer | via Walbrook PR |
Gareth Davies, Chief Financial Officer | |
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 |
Neil Baldwin | |
Oberon Capital Ltd (Broker) | Tel: +44 (0)203 179 5344 |
Mike Seabrook | mikeseabrook@oberoninvestments.com |
Walbrook PR Ltd (Media & Investor Relations) | Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com |
Paul McManus / Alice Woodings | Mob: +44 (0) 7980 541 893 / +44 (0)7407 804 654 |
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests. MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the acquisition of The Genome Store in November 2020. The tests will be made available online and would be viable for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market, with a focus on accessibility at the right price, led by UK-based experts.